Overlapping NMDA-R and GFAP Antibody Autoimmune Encephalitis After Nivolumab Therapy

The differential diagnosis associated with acute encephalopathy is broad; however, given the increasing frequency with which immunotherapy is being used in the treatment of cancer, consider checkpoint inhibitor-induced autoimmune encephalitis in the appropriate clinical context.

Read article at journal's website

Related Articles

Responses

Your email address will not be published. Required fields are marked *